This article was originally published on ETFTrends.com.
Loncar Investments has partnered up with Exchange Traded Concepts to launch a new ETF that tracks the growing biopharmaceutical sector in China. On Wednesday, Loncar Investments rolled out the Loncar China BioPharma ETF (NasdaqGM: CHNA), which has a 0.79% expense ratio. “China aims to become a leader in global medicine,” Brad Loncar, Chief Executive Officer […]
Continue Reading Below
